Considering that KDM4D is an essential molecular biomarker in ESCC and no selective inhibitors are available, we thus wondered whether HMGB1 inhibitor could be effective to treat ESCC, especially the KDM4Dlow tumors. The gene discussed is HMGB1; the disease is esophageal squamous cell carcinoma.